25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ACT (Alzchem) Stock Analysis
Buy, Hold or Sell?

Let's analyze Alzchem together

I guess you are interested in AlzChem Group AG. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Alzchem’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Alzchem’s Price Targets

I'm going to help you getting a better view of AlzChem Group AG. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about AlzChem Group AG

I send you an email if I find something interesting about AlzChem Group AG.

1. Quick Overview

1.1. Quick analysis of Alzchem (30 sec.)










1.2. What can you expect buying and holding a share of Alzchem? (30 sec.)

How much money do you get?

How much money do you get?
€1.35
When do you have the money?
1 year
How often do you get paid?
57.1%

What is your share worth?

Current worth
€21.96
Expected worth in 1 year
€26.33
How sure are you?
82.9%

+ What do you gain per year?

Total Gains per Share
€5.57
Return On Investment
4.6%

For what price can you sell your share?

Current Price per Share
€119.80
Expected price per share
€95.94 - €130.75
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Alzchem (5 min.)




Live pricePrice per Share (EOD)
€119.80
Intrinsic Value Per Share
€329.88 - €394.94
Total Value Per Share
€351.84 - €416.90

2.2. Growth of Alzchem (5 min.)




Is Alzchem growing?

Current yearPrevious yearGrowGrow %
How rich?$251.5m$184m$43.1m19.0%

How much money is Alzchem making?

Current yearPrevious yearGrowGrow %
Making money$15.9m$13.4m$2.4m15.4%
Net Profit Margin10.3%8.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Alzchem (5 min.)




2.4. Comparing to competitors in the Specialty Chemicals industry (5 min.)




  Industry Rankings (Specialty Chemicals)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Alzchem?

Welcome investor! Alzchem's management wants to use your money to grow the business. In return you get a share of Alzchem.

First you should know what it really means to hold a share of Alzchem. And how you can make/lose money.

Speculation

The Price per Share of Alzchem is €119.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Alzchem.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Alzchem, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €21.96. Based on the TTM, the Book Value Change Per Share is €1.09 per quarter. Based on the YOY, the Book Value Change Per Share is €0.68 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.30 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Alzchem.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 β‚¬% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share
Usd Eps1.621.4%1.571.3%1.321.1%1.241.0%1.030.9%0.780.7%
Usd Book Value Change Per Share1.721.4%1.231.0%0.770.6%1.010.8%0.790.7%0.710.6%
Usd Dividend Per Share0.000.0%0.340.3%0.300.2%0.600.5%0.720.6%0.580.5%
Usd Total Gains Per Share1.721.4%1.571.3%1.070.9%1.611.3%1.511.3%1.291.1%
Usd Price Per Share105.19-69.36-28.77-39.52-34.08-24.15-
Price to Earnings Ratio16.21-11.01-5.93-7.73-8.60-13.15-
Price-to-Total Gains Ratio61.32-44.59-47.45-33.90-26.68--88.74-
Price to Book Ratio4.24-3.06-1.57-1.98-2.38-1.85-
Price-to-Total Gains Ratio61.32-44.59-47.45-33.90-26.68--88.74-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share135.21826
Number of shares7
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.340.72
Usd Book Value Change Per Share1.230.79
Usd Total Gains Per Share1.571.51
Gains per Quarter (7 shares)11.0010.55
Gains per Year (7 shares)43.9942.20
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
193534202232
2196978404474
3281041226066116
4381381668088158
547173210100111200
657207254121133242
766242298141155284
876276342161177326
985311386181199368
1095345430201221410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%35.00.00.0100.0%35.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%16.04.00.080.0%22.010.03.062.9%22.010.03.062.9%
Dividend per Share1.00.03.025.0%6.00.06.050.0%14.00.06.070.0%20.00.015.057.1%20.00.015.057.1%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%29.05.01.082.9%29.05.01.082.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of AlzChem Group AG compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.5201.092+39%0.683+123%0.897+69%0.699+117%0.627+142%
Book Value Per Share--21.95919.813+11%16.026+37%16.602+32%13.129+67%9.632+128%
Current Ratio--2.7122.462+10%2.394+13%2.187+24%2.134+27%1.869+45%
Debt To Asset Ratio--0.6000.594+1%0.621-3%0.628-5%0.690-13%0.753-20%
Debt To Equity Ratio--1.5101.476+2%1.666-9%1.736-13%2.548-41%2.872-47%
Dividend Per Share---0.300-100%0.262-100%0.533-100%0.636-100%0.514-100%
Enterprise Value--612353560.000366777506.750+67%13402465.750+4469%95463726.917+541%40362319.050+1417%-15735856.090+103%
Eps--1.4381.389+3%1.173+23%1.100+31%0.909+58%0.694+107%
Ev To Sales Ratio--1.0580.660+60%0.013+7965%0.168+528%0.060+1676%-0.065+106%
Free Cash Flow Per Share--4.8782.437+100%1.919+154%1.444+238%0.954+411%0.572+753%
Free Cash Flow To Equity Per Share--4.8781.831+166%1.005+385%1.054+363%0.623+683%0.340+1336%
Gross Profit Margin--1.0000.917+9%0.830+20%0.856+17%0.860+16%0.814+23%
Intrinsic Value_10Y_max--394.943----------
Intrinsic Value_10Y_min--329.884----------
Intrinsic Value_1Y_max--10.685----------
Intrinsic Value_1Y_min--10.478----------
Intrinsic Value_3Y_max--54.123----------
Intrinsic Value_3Y_min--51.226----------
Intrinsic Value_5Y_max--124.106----------
Intrinsic Value_5Y_min--113.297----------
Market Cap1216065840.000+22%946054560.000624377007.000+52%259369465.750+265%356021810.333+166%307082769.100+208%217598937.595+335%
Net Profit Margin--0.1010.103-2%0.087+16%0.081+25%0.073+39%0.061+67%
Operating Margin---0.104-100%0.119-100%0.091-100%0.078-100%0.074-100%
Operating Ratio--1.2210.937+30%1.079+13%0.988+24%0.957+28%0.942+30%
Pb Ratio5.456+22%4.2443.057+39%1.571+170%1.976+115%2.375+79%1.849+130%
Pe Ratio20.833+22%16.20711.009+47%5.926+174%7.727+110%8.603+88%13.150+23%
Price Per Share119.800+22%93.20061.450+52%25.488+266%35.017+166%30.195+209%21.394+336%
Price To Free Cash Flow Ratio6.140+22%4.7761.687+183%4.720+1%4.157+15%-4.655+197%-4.374+192%
Price To Total Gains Ratio78.822+22%61.32144.588+38%47.451+29%33.901+81%26.685+130%-88.743+245%
Quick Ratio--0.7181.064-33%1.026-30%0.890-19%0.851-16%73.185-99%
Return On Assets--0.0260.029-8%0.028-6%0.025+7%0.022+21%4.967-99%
Return On Equity--0.0660.071-7%0.074-10%0.0660%0.072-8%0.068-3%
Total Gains Per Share--1.5201.392+9%0.945+61%1.430+6%1.335+14%1.141+33%
Usd Book Value--251586101.300227266848.643+11%184077989.950+37%190587202.756+32%150738167.119+67%110601861.193+127%
Usd Book Value Change Per Share--1.7151.232+39%0.771+123%1.012+69%0.789+117%0.708+142%
Usd Book Value Per Share--24.78522.363+11%18.089+37%18.738+32%14.819+67%10.872+128%
Usd Dividend Per Share---0.339-100%0.296-100%0.602-100%0.718-100%0.580-100%
Usd Enterprise Value--691163463.172413981771.869+67%15127363.092+4469%107749908.571+541%45556949.512+1417%-17761060.769+103%
Usd Eps--1.6231.568+3%1.324+23%1.242+31%1.026+58%0.783+107%
Usd Free Cash Flow--55889837.90027970314.700+100%22044357.525+154%16582860.400+237%10951437.490+410%6564390.206+751%
Usd Free Cash Flow Per Share--5.5062.751+100%2.166+154%1.630+238%1.077+411%0.645+753%
Usd Free Cash Flow To Equity Per Share--5.5062.067+166%1.135+385%1.190+363%0.703+683%0.383+1336%
Usd Market Cap1372573513.608+22%1067811781.872704734327.801+52%292750315.992+265%401841817.323+166%346604321.483+208%245603920.864+335%
Usd Price Per Share135.218+22%105.19569.359+52%28.768+266%39.523+166%34.081+209%24.147+336%
Usd Profit--16471119.10015935550.950+3%13476678.000+22%12627519.367+30%10432348.360+58%7967493.300+107%
Usd Revenue--163300316.000155026945.000+5%152460563.375+7%155475132.958+5%140476252.515+16%123698296.320+32%
Usd Total Gains Per Share--1.7151.571+9%1.067+61%1.614+6%1.507+14%1.288+33%
 EOD+4 -4MRQTTM+25 -14YOY+28 -113Y+29 -105Y+29 -1010Y+28 -11

3.3 Fundamental Score

Let's check the fundamental score of AlzChem Group AG based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1520.833
Price to Book Ratio (EOD)Between0-15.456
Net Profit Margin (MRQ)Greater than00.101
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.718
Current Ratio (MRQ)Greater than12.712
Debt to Asset Ratio (MRQ)Less than10.600
Debt to Equity Ratio (MRQ)Less than11.510
Return on Equity (MRQ)Greater than0.150.066
Return on Assets (MRQ)Greater than0.050.026
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of AlzChem Group AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.554
Ma 20Greater thanMa 50116.607
Ma 50Greater thanMa 100104.168
Ma 100Greater thanMa 20084.930
OpenGreater thanClose123.200
Total5/5 (100.0%)

4. In-depth Analysis

4.1 About AlzChem Group AG

AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, food, animal feed, defence technology, and renewable energies industries. This segment manufactures composite materials and adhesives, as well as silicon nitride for ceramics; and photovoltaic modules in the solar industry. The Basics & Intermediates segment produces raw materials for specialty chemicals; and products for agriculture and metallurgy, as well as intermediates for the chemical industry that are produced from lime, carbon, and electricity. This segment also engages in the production and sale of guanidine salts as a raw material for agrochemicals and active pharmaceutical ingredients. The Other & Holding segment provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. It offers products and services to agricultural sector under the CALCIUM CYANAMIDE PERLKA, EMINEX, DORMEX, ALZOGUR, SITOFEX, and BREAK-THRU brands; animal nutrition sector under the CREAMINO brands; human nutrition sector under the CREAPURE, CREAVITALIS, LIVADUR, and ALIPURE brands; pharma sector under the GUANIDINE SALTS " BIOSELECT brand; fine chemicals sector under the GUANIDINSALZE -BIOSELECT, CYANAMIDE, DICYANDIAMIDE, GUANAMINE, NITRILES, MELFLOCK and ALZOFIX, THIOUREA, and NITROGUANIDINE brands; metallurgy sector under the CAD, CALCIPRO, and CALZOT brands, as well as technical gases and calcium carbide; renewable energy sector under the DYHARD and SILZOT brands; and custom synthesis, such as toll micronization and manufacturing. The company was founded in 1908 and is based in Trostberg, Germany.

Fundamental data was last updated by Penke on 2025-05-13 08:42:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Alzchem earns for each €1 of revenue.

  • Above 10% is considered healthy but always compareΒ Alzchem to theΒ Specialty Chemicals industry mean.
  • A Net Profit Margin of 10.1%Β means thatΒ €0.10 for each €1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of AlzChem Group AG:

  • The MRQ is 10.1%. The company is making a huge profit. +2
  • The TTM is 10.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ10.1%TTM10.3%-0.2%
TTM10.3%YOY8.7%+1.6%
TTM10.3%5Y7.3%+3.0%
5Y7.3%10Y6.1%+1.2%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ10.1%3.6%+6.5%
TTM10.3%3.4%+6.9%
YOY8.7%3.9%+4.8%
3Y8.1%4.2%+3.9%
5Y7.3%5.5%+1.8%
10Y6.1%5.6%+0.5%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Alzchem is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Alzchem to theΒ Specialty Chemicals industry mean.
  • 2.6% Return on Assets means thatΒ Alzchem generatedΒ €0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of AlzChem Group AG:

  • The MRQ is 2.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.6%TTM2.9%-0.2%
TTM2.9%YOY2.8%+0.1%
TTM2.9%5Y2.2%+0.7%
5Y2.2%10Y496.7%-494.6%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6%0.8%+1.8%
TTM2.9%0.8%+2.1%
YOY2.8%1.0%+1.8%
3Y2.5%1.1%+1.4%
5Y2.2%1.3%+0.9%
10Y496.7%1.5%+495.2%
4.3.1.3. Return on Equity

Shows how efficient Alzchem is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Alzchem to theΒ Specialty Chemicals industry mean.
  • 6.6% Return on Equity means Alzchem generated €0.07Β for eachΒ €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of AlzChem Group AG:

  • The MRQ is 6.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 7.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ6.6%TTM7.1%-0.5%
TTM7.1%YOY7.4%-0.3%
TTM7.1%5Y7.2%-0.1%
5Y7.2%10Y6.8%+0.4%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ6.6%1.5%+5.1%
TTM7.1%1.5%+5.6%
YOY7.4%1.8%+5.6%
3Y6.6%2.0%+4.6%
5Y7.2%2.4%+4.8%
10Y6.8%2.6%+4.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of AlzChem Group AG.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Alzchem is operatingΒ .

  • Measures how much profit Alzchem makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Alzchem to theΒ Specialty Chemicals industry mean.
  • An Operating Margin of 0.0%Β means the company generated €0.00 Β for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of AlzChem Group AG:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM10.4%-10.4%
TTM10.4%YOY11.9%-1.5%
TTM10.4%5Y7.8%+2.6%
5Y7.8%10Y7.4%+0.3%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.9%-6.9%
TTM10.4%6.1%+4.3%
YOY11.9%4.7%+7.2%
3Y9.1%4.4%+4.7%
5Y7.8%6.7%+1.1%
10Y7.4%7.1%+0.3%
4.3.2.2. Operating Ratio

Measures how efficient Alzchem is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Specialty Chemicals industry mean).
  • An Operation Ratio of 1.22 means that the operating costs are €1.22 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of AlzChem Group AG:

  • The MRQ is 1.221. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.937. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ1.221TTM0.937+0.284
TTM0.937YOY1.079-0.142
TTM0.9375Y0.957-0.020
5Y0.95710Y0.942+0.014
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2211.569-0.348
TTM0.9371.437-0.500
YOY1.0791.091-0.012
3Y0.9881.249-0.261
5Y0.9571.168-0.211
10Y0.9421.099-0.157
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of AlzChem Group AG.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Alzchem is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Specialty Chemicals industry mean).
  • A Current Ratio of 2.71Β means the company has €2.71 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of AlzChem Group AG:

  • The MRQ is 2.712. The company is able to pay all its short-term debts. +1
  • The TTM is 2.462. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.712TTM2.462+0.250
TTM2.462YOY2.394+0.067
TTM2.4625Y2.134+0.328
5Y2.13410Y1.869+0.264
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7121.827+0.885
TTM2.4621.836+0.626
YOY2.3941.961+0.433
3Y2.1871.918+0.269
5Y2.1341.954+0.180
10Y1.8691.910-0.041
4.4.3.2. Quick Ratio

Measures if Alzchem is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Alzchem to theΒ Specialty Chemicals industry mean.
  • A Quick Ratio of 0.72Β means the company can pay off €0.72 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of AlzChem Group AG:

  • The MRQ is 0.718. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.064. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ0.718TTM1.064-0.346
TTM1.064YOY1.026+0.037
TTM1.0645Y0.851+0.213
5Y0.85110Y73.185-72.335
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7180.739-0.021
TTM1.0640.809+0.255
YOY1.0260.990+0.036
3Y0.8901.000-0.110
5Y0.8511.091-0.240
10Y73.1851.131+72.054
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of AlzChem Group AG.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of AlzchemΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Alzchem to Specialty Chemicals industry mean.
  • A Debt to Asset Ratio of 0.60Β means that Alzchem assets areΒ financed with 60.0% credit (debt) and the remaining percentage (100% - 60.0%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of AlzChem Group AG:

  • The MRQ is 0.600. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.594. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.600TTM0.594+0.006
TTM0.594YOY0.621-0.027
TTM0.5945Y0.690-0.096
5Y0.69010Y0.753-0.064
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6000.421+0.179
TTM0.5940.421+0.173
YOY0.6210.424+0.197
3Y0.6280.423+0.205
5Y0.6900.419+0.271
10Y0.7530.431+0.322
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Alzchem is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Alzchem to theΒ Specialty Chemicals industry mean.
  • A Debt to Equity ratio of 151.0% means that company has €1.51 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of AlzChem Group AG:

  • The MRQ is 1.510. The company is just able to pay all its debts with equity.
  • The TTM is 1.476. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.510TTM1.476+0.034
TTM1.476YOY1.666-0.190
TTM1.4765Y2.548-1.072
5Y2.54810Y2.872-0.323
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5100.739+0.771
TTM1.4760.754+0.722
YOY1.6660.747+0.919
3Y1.7360.758+0.978
5Y2.5480.792+1.756
10Y2.8720.826+2.046
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every €1 in earnings Alzchem generates.

  • Above 15 is considered overpriced butΒ always compareΒ Alzchem to theΒ Specialty Chemicals industry mean.
  • A PE ratio of 16.21 means the investor is paying €16.21Β for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of AlzChem Group AG:

  • The EOD is 20.833. Based on the earnings, the company is fair priced.
  • The MRQ is 16.207. Based on the earnings, the company is fair priced.
  • The TTM is 11.009. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD20.833MRQ16.207+4.626
MRQ16.207TTM11.009+5.198
TTM11.009YOY5.926+5.083
TTM11.0095Y8.603+2.406
5Y8.60310Y13.150-4.547
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD20.83318.347+2.486
MRQ16.20717.866-1.659
TTM11.00917.067-6.058
YOY5.92616.225-10.299
3Y7.72717.840-10.113
5Y8.60319.622-11.019
10Y13.15024.601-11.451
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of AlzChem Group AG:

  • The EOD is 6.140. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 4.776. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 1.687. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD6.140MRQ4.776+1.363
MRQ4.776TTM1.687+3.090
TTM1.687YOY4.720-3.034
TTM1.6875Y-4.655+6.341
5Y-4.65510Y-4.374-0.281
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD6.1402.981+3.159
MRQ4.7763.400+1.376
TTM1.6873.505-1.818
YOY4.7203.417+1.303
3Y4.1571.792+2.365
5Y-4.6553.446-8.101
10Y-4.3742.861-7.235
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Alzchem is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Specialty Chemicals industry mean).
  • A PB ratio of 4.24 means the investor is paying €4.24Β for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of AlzChem Group AG:

  • The EOD is 5.456. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.244. Based on the equity, the company is fair priced.
  • The TTM is 3.057. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.456MRQ4.244+1.211
MRQ4.244TTM3.057+1.188
TTM3.057YOY1.571+1.486
TTM3.0575Y2.375+0.681
5Y2.37510Y1.849+0.526
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD5.4561.619+3.837
MRQ4.2441.640+2.604
TTM3.0571.698+1.359
YOY1.5711.799-0.228
3Y1.9761.921+0.055
5Y2.3752.238+0.137
10Y1.8492.763-0.914
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets556,600
Total Liabilities333,701
Total Stockholder Equity220,965
 As reported
Total Liabilities 333,701
Total Stockholder Equity+ 220,965
Total Assets = 556,600

Assets

Total Assets556,600
Total Current Assets319,746
Long-term Assets236,854
Total Current Assets
Cash And Cash Equivalents 91,374
Net Receivables 84,612
Inventory 111,782
Total Current Assets  (as reported)319,746
Total Current Assets  (calculated)287,768
+/- 31,978
Long-term Assets
Property Plant Equipment 200,324
Intangible Assets 7,353
Long-term Assets Other 11,686
Long-term Assets  (as reported)236,854
Long-term Assets  (calculated)219,363
+/- 17,491

Liabilities & Shareholders' Equity

Total Current Liabilities117,922
Long-term Liabilities215,779
Total Stockholder Equity220,965
Total Current Liabilities
Total Current Liabilities  (as reported)117,922
Total Current Liabilities  (calculated)0
+/- 117,922
Long-term Liabilities
Long-term Liabilities  (as reported)215,779
Long-term Liabilities  (calculated)0
+/- 215,779
Total Stockholder Equity
Total Stockholder Equity (as reported)220,965
Total Stockholder Equity (calculated)0
+/- 220,965
Other
Common Stock Shares Outstanding 10,151
Net Working Capital 201,824



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312015-06-302014-12-312014-06-302013-12-312013-06-302011-12-312011-06-302010-12-312010-06-30
> Total Assets 
64
55
22
17
14
14
15
25
19
37
56
261,112
64
0
77
272,855
280,181
295,481
0
306,614
313,551
347,577
359,800
344,252
342,583
338,938
354,324
342,474
354,296
359,160
365,560
381,270
377,667
403,974
427,886
436,683
422,860
435,372
419,234
429,130
424,677
447,808
463,425
480,184
483,826
556,600
556,600483,826480,184463,425447,808424,677429,130419,234435,372422,860436,683427,886403,974377,667381,270365,560359,160354,296342,474354,324338,938342,583344,252359,800347,577313,551306,6140295,481280,181272,85577064261,1125637192515141417225564
   > Total Current Assets 
64
55
22
17
14
14
15
13
19
14
22
126,519
12
14,089
14
139,552
137,517
150,972
0
152,994
142,551
165,412
169,737
147,007
130,603
136,188
145,722
132,377
132,455
140,371
144,988
159,194
152,582
187,378
217,913
226,673
214,637
228,657
215,800
227,563
216,581
241,962
255,925
266,233
261,795
319,746
319,746261,795266,233255,925241,962216,581227,563215,800228,657214,637226,673217,913187,378152,582159,194144,988140,371132,455132,377145,722136,188130,603147,007169,737165,412142,551152,9940150,972137,517139,5521414,08912126,5192214191315141417225564
       Cash And Cash Equivalents 
64
47
14
8
4
13
15
13
17
7
12
14,973
12,089
-14,089
3
12,742
12,802
12,926
0
11,364
12,857
17,734
14,025
9,980
9,061
10,057
10,099
12,609
17,117
11,234
10,783
6,905
8,285
8,435
10,196
9,506
9,243
8,126
9,299
16,732
11,883
35,997
46,067
40,615
61,544
91,374
91,37461,54440,61546,06735,99711,88316,7329,2998,1269,2439,50610,1968,4358,2856,90510,78311,23417,11712,60910,09910,0579,0619,98014,02517,73412,85711,364012,92612,80212,7423-14,08912,08914,9731271713151348144764
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
2,000
28,178
0
36
499
0
0
0
190
2,666
2,150
-624
189
0
6
0
355
0
0
0
446
0
0
0
375
4,423
3,066
1,748
5,902
0
0
0
1,607
0
01,6070005,9021,7483,0664,423375000446000355060189-6242,1502,66619000049936028,1782,000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
35,954
0
46,901
43,330
0
0
79,453
42,515
49,909
0
66,536
40,040
46,887
53,624
45,736
37,588
39,328
50,018
32,075
37,228
47,248
50,065
56,554
46,219
50,813
57,782
52,482
61,846
76,838
54,636
63,069
81,837
88,388
76,884
75,951
84,507
84,612
84,61284,50775,95176,88488,38881,83763,06954,63676,83861,84652,48257,78250,81346,21956,55450,06547,24837,22832,07550,01839,32837,58845,73653,62446,88740,04066,536049,90942,51579,4530043,33046,901035,954000000000
       Other Current Assets 
0
8
8
10
9
1
0
0
2
7
10
8,035
10
0
11
16,665
10,396
13,235
0
-1
10,798
14,013
16,333
17,836
9,347
12,297
12,130
14,111
11,185
15,729
16,764
21,177
12,270
20,510
23,038
33,203
21,230
23,733
25,373
22,493
15,564
20,184
25,056
118,215
15,326
0
015,326118,21525,05620,18415,56422,49325,37323,73321,23033,20323,03820,51012,27021,17716,76415,72911,18514,11112,13012,2979,34717,83616,33314,01310,798-1013,23510,39616,665110108,0351072001910880
   > Long-term Assets 
0
0
0
0
0
4
0
12
0
23
34
134,593
52
-14,089
63
133,303
142,664
144,509
0
155,048
171,000
182,165
190,063
198,753
211,980
202,750
208,602
210,097
221,841
218,789
220,572
222,076
225,085
216,595
209,973
210,010
208,223
206,715
203,434
201,566
208,096
205,846
207,500
213,951
222,031
236,854
236,854222,031213,951207,500205,846208,096201,566203,434206,715208,223210,010209,973216,595225,085222,076220,572218,789221,841210,097208,602202,750211,980198,753190,063182,165171,000155,0480144,509142,664133,30363-14,08952134,59334230120400000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
91,427
0
90,654
96,372
0
0
106,399
115,131
117,060
0
128,433
144,265
153,005
158,545
163,961
175,472
172,831
171,777
172,819
183,586
183,443
184,726
184,581
186,493
185,340
187,251
187,442
187,776
185,204
176,826
176,435
182,136
176,798
183,521
185,482
168,151
200,324
200,324168,151185,482183,521176,798182,136176,435176,826185,204187,776187,442187,251185,340186,493184,581184,726183,443183,586172,819171,777172,831175,472163,961158,545153,005144,265128,4330117,060115,131106,3990096,37290,654091,427000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,383
0
0
0
0004,383000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
1,103
0
796
807
0
0
822
1,009
0
0
0
870
867
941
1,153
1,541
1,410
1,360
1,311
1,810
1,670
1,767
1,754
2,329
2,257
2,267
2,568
2,954
2,997
8,514
8,369
3,664
8,535
3,702
7,570
3,671
7,353
7,3533,6717,5703,7028,5353,6648,3698,5142,9972,9542,5682,2672,2572,3291,7541,7671,6701,8101,3111,3601,4101,5411,1539418678700001,0098220080779601,103000000000
       Other Assets 
0
0
0
0
0
-4
0
0
0
0
0
0
1
0
0
0
0
0
0
-1,428
0
0
0
-1,508
43,994
28,489
35,445
35,947
57,000
33,656
34,059
35,721
47,640
1
20,435
19,994
26,828
0
18,088
1
0
0
0
0
0
0
000000118,088026,82819,99420,435147,64035,72134,05933,65657,00035,94735,44528,48943,994-1,508000-1,4280000001000000-400000
> Total Liabilities 
38
38
5
5
5
12
16
25
18
37
56
218,700
64
0
77
214,953
222,287
230,716
0
229,736
245,160
279,902
300,648
287,882
281,233
257,830
291,599
278,463
285,638
276,412
283,786
299,962
288,103
290,023
295,796
297,444
276,914
284,146
270,900
267,688
261,118
268,789
280,873
287,695
276,355
333,701
333,701276,355287,695280,873268,789261,118267,688270,900284,146276,914297,444295,796290,023288,103299,962283,786276,412285,638278,463291,599257,830281,233287,882300,648279,902245,160229,7360230,716222,287214,95377064218,7005637182516125553838
   > Total Current Liabilities 
0
32
5
0
0
0
0
0
0
25
55
57,985
54
0
76
73,210
76,009
84,206
0
74,950
81,157
76,778
91,483
69,991
60,485
61,316
73,051
59,296
59,871
63,056
70,959
82,635
76,125
104,718
141,166
148,098
132,106
107,708
97,782
102,282
82,631
95,835
109,943
114,551
105,399
117,922
117,922105,399114,551109,94395,83582,631102,28297,782107,708132,106148,098141,166104,71876,12582,63570,95963,05659,87159,29673,05161,31660,48569,99191,48376,77881,15774,950084,20676,00973,2107605457,98555250000005320
       Short-term Debt 
0
0
0
0
0
0
0
0
0
4,732
0
5,641
5,601
0
0
15,942
22,122
29,580
0
0
25,353
74,950
33,851
0
13,641
0
27,041
0
14,338
0
14,757
0
12,295
28,483
62,487
0
68,115
0
23,381
0
10,446
0
10,964
0
9,415
0
09,415010,964010,446023,381068,115062,48728,48312,295014,757014,338027,041013,641033,85174,95025,3530029,58022,12215,942005,6015,64104,732000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32,443
0
11,935
0
25,473
0
12,704
0
12,407
0
10,490
26,708
60,750
0
66,408
0
21,788
0
8,833
0
9,303
0
7,589
0
07,58909,30308,833021,788066,408060,75026,70810,490012,407012,704025,473011,935032,4430000000000000000000000
       Accounts payable 
0
32
0
0
0
0
0
0
0
2
16
18,603
21,701
0
1
22,449
28,199
24,587
0
0
30,863
0
25,606
0
24,069
0
23,871
0
20,880
0
28,537
0
32,780
42,358
44,778
0
37,386
0
38,709
0
31,554
0
51,471
0
37,425
0
037,425051,471031,554038,709037,386044,77842,35832,780028,537020,880023,871024,069025,606030,8630024,58728,19922,4491021,70118,6031620000000320
       Other Current Liabilities 
0
0
5
0
0
0
0
0
0
23
39
33,741
54
0
75
21,966
18,897
26,731
0
74,950
18,032
1,828
19,030
69,991
16,047
61,316
14,575
59,296
18,346
63,056
17,076
82,635
22,188
31,235
30,943
148,098
18,526
107,708
19,951
102,282
24,303
95,835
35,041
114,551
38,715
0
038,715114,55135,04195,83524,303102,28219,951107,70818,526148,09830,94331,23522,18882,63517,07663,05618,34659,29614,57561,31616,04769,99119,0301,82818,03274,950026,73118,89721,9667505433,7413923000000500
   > Long-term Liabilities 
38
6
0
5
5
12
16
25
17
12
2
160,715
10
0
2
141,743
146,278
146,510
0
154,786
164,003
203,124
209,165
217,891
220,748
196,514
218,548
219,167
225,767
213,356
212,827
217,327
211,978
185,305
154,630
149,346
144,808
176,438
173,118
165,406
178,487
172,954
170,930
173,144
170,956
215,779
215,779170,956173,144170,930172,954178,487165,406173,118176,438144,808149,346154,630185,305211,978217,327212,827213,356225,767219,167218,548196,514220,748217,891209,165203,124164,003154,7860146,510146,278141,7432010160,71521217251612550638
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54,722
0
48,141
0
43,346
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000043,346048,141054,7220000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
217,891
162,291
196,514
166,626
219,167
171,045
213,356
164,686
217,327
168,632
185,304
117,017
149,346
112,688
0
116,029
165,406
0
0
0
0
0
0
000000165,406116,0290112,688149,346117,017185,304168,632217,327164,686213,356171,045219,167166,626196,514162,291217,89100000000000000000000000
> Total Stockholder Equity
27
17
17
13
9
2
-1
-41,474
1
-41,494
-41,494
42,325
-51
53,487
-51
55,687
55,670
62,559
0
76,878
66,971
66,255
57,645
56,370
59,758
79,516
61,047
62,333
66,895
80,985
79,926
79,460
87,630
111,974
130,070
137,219
144,012
149,292
146,314
159,422
161,625
177,085
180,532
192,489
205,537
220,965
220,965205,537192,489180,532177,085161,625159,422146,314149,292144,012137,219130,070111,97487,63079,46079,92680,98566,89562,33361,04779,51659,75856,37057,64566,25566,97176,878062,55955,67055,687-5153,487-5142,325-41,494-41,4941-41,474-12913171727
   Common Stock
310
310
310
310
310
310
310
310
310
310
310
11,000
310
0
310
11,000
101,763
101,763
0
0
101,763
67,675
101,763
57,877
101,763
81,108
101,763
64,011
101,763
82,748
101,763
81,308
101,763
101,763
101,763
139,239
101,763
151,226
101,763
161,442
101,763
179,019
101,763
0
101,763
0
0101,7630101,763179,019101,763161,442101,763151,226101,763139,239101,763101,763101,76381,308101,76382,748101,76364,011101,76381,108101,76357,877101,76367,675101,76300101,763101,76311,000310031011,000310310310310310310310310310310310
   Retained Earnings 
-41,757
-41,767
0
-41,771
-41,775
-41,782
-41,785
-41,784
-41,803
-41,804
-41,804
44,975
-361
0
-361
47,493
49,047
23,943
0
0
60,478
0
19,030
0
21,142
0
72,750
0
28,279
0
42,317
0
101,127
108,825
108,276
0
121,044
0
125,223
0
144,979
0
159,346
0
186,844
0
0186,8440159,3460144,9790125,2230121,0440108,276108,825101,127042,317028,279072,750021,142019,030060,4780023,94349,04747,493-3610-36144,975-41,804-41,804-41,803-41,784-41,785-41,782-41,775-41,7710-41,767-41,757
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,981
0
24,981
0
24,981
0
24,981
0
24,981
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000024,981024,981024,981024,981024,981000000000000000000000000
   Treasury Stock0000000000000-1,0090-1,007000000000000000000000000000000
   Other Stockholders Equity 
41,474
41,474
-293
41,474
41,474
41,474
41,474
41,474
41,494
41,494
0
0
51
137
51
-5,613
50,615
-63,147
0
76,878
-95,270
67,675
-151,429
-1,507
-111,299
81,108
-163,785
-1,678
125,183
82,748
-160,706
81,308
-166,364
-110,802
-95,782
139,239
-94,111
149,292
-97,866
-2,020
-85,117
-1,934
-80,577
192,489
-83,070
0
0-83,070192,489-80,577-1,934-85,117-2,020-97,866149,292-94,111139,239-95,782-110,802-166,36481,308-160,70682,748125,183-1,678-163,78581,108-111,299-1,507-151,42967,675-95,27076,8780-63,14750,615-5,61351137510041,49441,49441,47441,47441,47441,47441,474-29341,47441,474



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue554,231
Cost of Revenue-214,967
Gross Profit339,264339,264
 
Operating Income (+$)
Gross Profit339,264
Operating Expense-175,118
Operating Income173,354164,146
 
Operating Expense (+$)
Research Development10,831
Selling General Administrative11,935
Selling And Marketing Expenses20,055
Operating Expense175,11842,821
 
Net Interest Income (+$)
Interest Income2,174
Interest Expense-2,297
Other Finance Cost-3,484
Net Interest Income-3,607
 
Pretax Income (+$)
Operating Income173,354
Net Interest Income-3,607
Other Non-Operating Income Expenses0
Income Before Tax (EBT)75,343271,365
EBIT - interestExpense = 78,878
75,172
56,372
Interest Expense2,297
Earnings Before Interest and Taxes (EBIT)81,17577,640
Earnings Before Interest and Taxes (EBITDA)107,493
 
After tax Income (+$)
Income Before Tax75,343
Tax Provision-21,097
Net Income From Continuing Ops54,24654,246
Net Income54,075
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses390,085
Total Other Income/Expenses Net-98,0113,607
 

Technical Analysis of Alzchem
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Alzchem. The general trend of Alzchem is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Alzchem's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Alzchem Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of AlzChem Group AG.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 130.75.

The bearish price targets are: 109.45 > 107.28 > 95.94.

Know someone who trades $ACT? Share this with them.πŸ‘‡

AlzChem Group AG Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of AlzChem Group AG. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

AlzChem Group AG Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of AlzChem Group AG. The current macd is 6.01468986.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Alzchem price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Alzchem. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Alzchem price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
AlzChem Group AG Daily Moving Average Convergence/Divergence (MACD) ChartAlzChem Group AG Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of AlzChem Group AG. The current adx is 25.57.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Alzchem shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
AlzChem Group AG Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of AlzChem Group AG. The current sar is 130.11.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
AlzChem Group AG Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of AlzChem Group AG. The current rsi is 58.55. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
AlzChem Group AG Daily Relative Strength Index (RSI) ChartAlzChem Group AG Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of AlzChem Group AG. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Alzchem price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
AlzChem Group AG Daily Stochastic Oscillator ChartAlzChem Group AG Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of AlzChem Group AG. The current cci is 28.11.

AlzChem Group AG Daily Commodity Channel Index (CCI) ChartAlzChem Group AG Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of AlzChem Group AG. The current cmo is 7.83569787.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
AlzChem Group AG Daily Chande Momentum Oscillator (CMO) ChartAlzChem Group AG Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of AlzChem Group AG. The current willr is -56.07092905.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Alzchem is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
AlzChem Group AG Daily Williams %R ChartAlzChem Group AG Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of AlzChem Group AG.

AlzChem Group AG Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of AlzChem Group AG. The current atr is 6.5214928.

AlzChem Group AG Daily Average True Range (ATR) ChartAlzChem Group AG Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of AlzChem Group AG. The current obv is 737,191.

AlzChem Group AG Daily On-Balance Volume (OBV) ChartAlzChem Group AG Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of AlzChem Group AG. The current mfi is 53.34.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
AlzChem Group AG Daily Money Flow Index (MFI) ChartAlzChem Group AG Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for AlzChem Group AG.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-12-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-30STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-01-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-31WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-18ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-02STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-20STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

AlzChem Group AG Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of AlzChem Group AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.554
Ma 20Greater thanMa 50116.607
Ma 50Greater thanMa 100104.168
Ma 100Greater thanMa 20084.930
OpenGreater thanClose123.200
Total5/5 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Alzchem with someone you think should read this too:
  • Are you bullish or bearish on Alzchem? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Alzchem? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about AlzChem Group AG

I send you an email if I find something interesting about AlzChem Group AG.


Comments

How you think about this?

Leave a comment

Stay informed about AlzChem Group AG.

Receive notifications about AlzChem Group AG in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.